{"log_id": 5406972939619080048, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 0, "average": 0.939769, "min": 0.939769}, "location": {"width": 98, "top": 43, "height": 98, "left": 1458}, "words": "⑦"}, {"probability": {"variance": 0.004274, "average": 0.977181, "min": 0.76062}, "location": {"width": 337, "top": 135, "height": 34, "left": 264}, "words": "4个及以上巴结阳性的患者"}, {"probability": {"variance": 0.022833, "average": 0.91051, "min": 0.368492}, "location": {"width": 1190, "top": 176, "height": 48, "left": 312}, "words": "在4个及以上巴结附性惠老中观察到的无病生存期(DFS)和忘生存(OS的获益未达到统计学显"}, {"probability": {"variance": 0.023773, "average": 0.859519, "min": 0.439776}, "location": {"width": 1093, "top": 206, "height": 45, "left": 259}, "words": "老性:此TA在及以上淋巴结性者中的正妆益/风玲比在最对末得到完全证文"}, {"probability": {"variance": 0, "average": 0.999912, "min": 0.99989}, "location": {"width": 50, "top": 266, "height": 27, "left": 259}, "words": "老年"}, {"probability": {"variance": 0.013374, "average": 0.938088, "min": 0.513055}, "location": {"width": 622, "top": 310, "height": 39, "left": 342}, "words": "安在首次接受化疗的非小红胞肺癌患者中进行的研究"}, {"probability": {"variance": 0.043052, "average": 0.89057, "min": 0.408606}, "location": {"width": 363, "top": 317, "height": 39, "left": 1137}, "words": "接受多西和铂治疗的患"}, {"probability": {"variance": 0.015148, "average": 0.942199, "min": 0.532708}, "location": {"width": 1242, "top": 337, "height": 50, "left": 257}, "words": "者中,有14日例的年龄大干等于65岁,15例忠者的年龄大于等于75岁;年龄轻人的患者与年经患老"}, {"probability": {"variance": 0.002005, "average": 0.985912, "min": 0.808647}, "location": {"width": 539, "top": 372, "height": 32, "left": 255}, "words": "进行比后,发二在治疗效果上没有差异"}, {"probability": {"variance": 0.026591, "average": 0.904231, "min": 0.355604}, "location": {"width": 1192, "top": 411, "height": 48, "left": 307}, "words": "受多西他赛和顺铂治疗的老华出者与接受长春瑞滨和顺铂的老年者相比,前老腹泻和3/4度神经"}, {"probability": {"variance": 0.012612, "average": 0.947117, "min": 0.598114}, "location": {"width": 328, "top": 441, "height": 34, "left": 252}, "words": "毒性的发生率有增多的趋势"}, {"probability": {"variance": 0.015449, "average": 0.944871, "min": 0.523948}, "location": {"width": 1187, "top": 482, "height": 48, "left": 310}, "words": "在一项33名前列腺癌患者接受多西他赛3周治疗方案的研究中,209名患者为65岁或以上,68名患"}, {"probability": {"variance": 0.019412, "average": 0.940438, "min": 0.373061}, "location": {"width": 1240, "top": 510, "height": 50, "left": 252}, "words": "75岁以上。在老年思老和年轻患者中末显示疗效差异。在接受多西地赛3周治疗方的患中,与小十"}, {"probability": {"variance": 0.029519, "average": 0.903765, "min": 0.388091}, "location": {"width": 1201, "top": 542, "height": 45, "left": 252}, "words": "6:岁的志相比,65岁或以上患者的贫血、感染、指甲改变、和体减轻的发生率增高10%以上"}, {"probability": {"variance": 0.002428, "average": 0.968837, "min": 0.875655}, "location": {"width": 192, "top": 613, "height": 34, "left": 248}, "words": "安全处置建议:"}, {"probability": {"variance": 0.012323, "average": 0.960384, "min": 0.569193}, "location": {"width": 383, "top": 654, "height": 36, "left": 248}, "words": "细胞击类药物应按以下指导操作"}, {"probability": {"variance": 0.009646, "average": 0.948613, "min": 0.649038}, "location": {"width": 567, "top": 700, "height": 36, "left": 333}, "words": "药物配制只能由受过培训的人员在指定地点操作"}, {"probability": {"variance": 0.012508, "average": 0.938826, "min": 0.461667}, "location": {"width": 1072, "top": 742, "height": 48, "left": 335}, "words": "多西他赛为一抗瘤药物,当与其它有毒化合物同时使用时:在处理及配制药液时要格外小吃"}, {"probability": {"variance": 0.052729, "average": 0.824477, "min": 0.375445}, "location": {"width": 434, "top": 790, "height": 32, "left": 358}, "words": "作台表面应覆以可丢弃的塑覆腆纸"}, {"probability": {"variance": 0.029757, "average": 0.881982, "min": 0.467999}, "location": {"width": 255, "top": 831, "height": 29, "left": 319}, "words": "穿黛护手套及衣服"}, {"probability": {"variance": 0.011923, "average": 0.934662, "min": 0.537035}, "location": {"width": 1164, "top": 870, "height": 50, "left": 333}, "words": "如果多西他赛注射液,预注射液或注射溶液接触了皮肤,立即肥皂和水彻底清洗。如果多西他"}, {"probability": {"variance": 0.005111, "average": 0.971642, "min": 0.646674}, "location": {"width": 836, "top": 902, "height": 39, "left": 333}, "words": "賽注射液,预注射液或注射溶液接触了眼睛或粘膜,立即用水底洗"}, {"probability": {"variance": 0.002678, "average": 0.978542, "min": 0.802501}, "location": {"width": 374, "top": 946, "height": 32, "left": 330}, "words": "细胞药物不能由怀孕人员处置"}, {"probability": {"variance": 4.2e-05, "average": 0.995037, "min": 0.979429}, "location": {"width": 321, "top": 990, "height": 32, "left": 328}, "words": "处废弃药品时要格外小心"}, {"probability": {"variance": 0, "average": 0.980344, "min": 0.980344}, "location": {"width": 388, "top": 997, "height": 94, "left": 985}, "words": "乐"}, {"probability": {"variance": 0, "average": 0.999787, "min": 0.999787}, "location": {"width": 18, "top": 1089, "height": 25, "left": 1442}, "words": "3"}, {"probability": {"variance": 2.9e-05, "average": 0.995856, "min": 0.980059}, "location": {"width": 328, "top": 1288, "height": 41, "left": 238}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.011408, "average": 0.944485, "min": 0.536725}, "location": {"width": 1187, "top": 1332, "height": 48, "left": 294}, "words": "尚无多西他赛用干虹娠妇女的资料。多西他赛在兔及鼠中显示有胚胎及胎儿毒性,及在鼠中降低其"}, {"probability": {"variance": 0.015152, "average": 0.936306, "min": 0.561476}, "location": {"width": 1247, "top": 1357, "height": 52, "left": 234}, "words": "生育的能力。与共他细胞毒药物一样,当妊娠妇女使用多西他赛时可能对胎儿有损伤,因此,西他赛"}, {"probability": {"variance": 0.017674, "average": 0.948755, "min": 0.41964}, "location": {"width": 884, "top": 1389, "height": 45, "left": 232}, "words": "不能用于娠妇女。应告诚育龄期妇女在接受多匹他赛治疗时应避免怀孕"}, {"probability": {"variance": 0.039085, "average": 0.890099, "min": 0.40678}, "location": {"width": 305, "top": 1401, "height": 32, "left": 1171}, "words": "怀孕应即通知治疗医"}, {"probability": {"variance": 0, "average": 0.99167, "min": 0.99167}, "location": {"width": 25, "top": 1424, "height": 25, "left": 234}, "words": "生"}, {"probability": {"variance": 0.000191, "average": 0.991254, "min": 0.947693}, "location": {"width": 705, "top": 1474, "height": 41, "left": 294}, "words": "多西他赛为亲酯性物质,但尚未知是否能从人体乳汁中排出"}, {"probability": {"variance": 0.007288, "average": 0.956787, "min": 0.663614}, "location": {"width": 971, "top": 1516, "height": 48, "left": 294}, "words": "而且,由于其潜在的对哺乳婴儿的不良反应,在多西他赛治疗期间应停止母乳哏养"}, {"probability": {"variance": 0.000168, "average": 0.987658, "min": 0.962112}, "location": {"width": 165, "top": 1589, "height": 34, "left": 236}, "words": "【儿童用药】"}, {"probability": {"variance": 0.019244, "average": 0.932191, "min": 0.556575}, "location": {"width": 484, "top": 1638, "height": 34, "left": 291}, "words": "多西他赛应用于儿童和青少年的经欤有限"}, {"probability": {"variance": 0.001544, "average": 0.969666, "min": 0.903406}, "location": {"width": 165, "top": 1704, "height": 36, "left": 234}, "words": "【老年用药】"}, {"probability": {"variance": 0.005295, "average": 0.962659, "min": 0.73069}, "location": {"width": 735, "top": 1750, "height": 39, "left": 289}, "words": "老年人:据群体药代动力学数据结果,对老年人月药没有特"}, {"probability": {"variance": 0.009657, "average": 0.960669, "min": 0.523534}, "location": {"width": 811, "top": 1794, "height": 36, "left": 287}, "words": "尚无年龄70岁患者使用多西他赛联合阿霉素及环磷酸治疗的资料"}, {"probability": {"variance": 0.009761, "average": 0.940409, "min": 0.700983}, "location": {"width": 220, "top": 1863, "height": 34, "left": 229}, "words": "【药物相互作用丨"}, {"probability": {"variance": 0.021798, "average": 0.934736, "min": 0.416656}, "location": {"width": 647, "top": 1909, "height": 36, "left": 287}, "words": "尚元止式临资料评估多西他赛与其他药物的相互作用"}, {"probability": {"variance": 0.013002, "average": 0.647782, "min": 0.533756}, "location": {"width": 151, "top": 1913, "height": 45, "left": 1316}, "words": "住木"}, {"probability": {"variance": 0.014338, "average": 0.942483, "min": 0.366373}, "location": {"width": 1185, "top": 1950, "height": 43, "left": 284}, "words": "体外研究表明多西他赛的代谢可能因合并用药而改变,这些能诱导、抑制或被细角P450-3A代"}, {"probability": {"variance": 0.01903, "average": 0.929377, "min": 0.483502}, "location": {"width": 1307, "top": 1966, "height": 62, "left": 222}, "words": "谢《从而可能竞争性扣制该酶)如环泡素,特非那定,酮康唑,红霉素及醋竹桃霉浓者合使用"}, {"probability": {"variance": 0.010743, "average": 0.966223, "min": 0.513975}, "location": {"width": 661, "top": 2012, "height": 32, "left": 222}, "words": "以上约物时,因为潜在的显著药物问作用,应加以注意"}, {"probability": {"variance": 0.024195, "average": 0.926781, "min": 0.441995}, "location": {"width": 1240, "top": 2051, "height": 45, "left": 287}, "words": "多西他赛的蛋白结合率高(>9%)。尽管尚未正式研究过多西赛与其他药物的体相互作,体"}, {"probability": {"variance": 0.013861, "average": 0.936203, "min": 0.403056}, "location": {"width": 1279, "top": 2079, "height": 48, "left": 220}, "words": "外试验显示易与蛋白结合的药物如红霉素,苯海拉明,普恭洛尔,善罗帕酮,苯妥英水杨酸盐,磺接"}, {"probability": {"variance": 0.010689, "average": 0.964869, "min": 0.489403}, "location": {"width": 1247, "top": 2104, "height": 55, "left": 220}, "words": "甲恶唑及丙戊酸钠不影响多西他赛与蛋白的结合。此外,地塞米松不影响多西他赛的蛋白多西"}, {"probability": {"variance": 0.002433, "average": 0.977013, "min": 0.837929}, "location": {"width": 441, "top": 2143, "height": 29, "left": 222}, "words": "他不影响洋地黄毒苷的蛋白结合率"}, {"probability": {"variance": 0.001264, "average": 0.973479, "min": 0.923226}, "location": {"width": 82, "top": 2226, "height": 29, "left": 218}, "words": "-24"}, {"probability": {"variance": 0.043493, "average": 0.61026, "min": 0.385866}, "location": {"width": 333, "top": 2230, "height": 45, "left": 1164}, "words": "上511"}], "language": 3}